BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 26321494)

  • 1. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
    Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
    Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
    Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
    Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
    Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
    Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of texture analysis for grading pancreatic neuroendocrine tumors on contrast-enhanced computed tomography and apparent diffusion coefficient maps.
    Ohki K; Igarashi T; Ashida H; Takenaga S; Shiraishi M; Nozawa Y; Ojiri H
    Jpn J Radiol; 2021 Jan; 39(1):66-75. PubMed ID: 32885378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
    Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
    Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
    Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
    Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors.
    Wan Y; Hao H; Meng S; Li Z; Yu F; Meng Chi ; Chao Q; Gao J
    Pancreatology; 2021 Jan; 21(1):240-245. PubMed ID: 33191144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology.
    Zamboni GA; Ambrosetti MC; Zivelonghi C; Lombardo F; Butturini G; Cingarlini S; Capelli P; Pozzi Mucelli R
    HPB (Oxford); 2017 Nov; 19(11):986-991. PubMed ID: 28784262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
    Li JK; Wang M; Yuan J; Song ZG
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis.
    Kim C; Byun JH; Hong SM; An S; Kim JH; Lee SS; Kim HJ
    Abdom Radiol (NY); 2017 Dec; 42(12):2835-2842. PubMed ID: 28624923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.
    Belousova E; Karmazanovsky G; Kriger A; Kalinin D; Mannelli L; Glotov A; Karelskaya N; Paklina O; Kaldarov A
    Clin Radiol; 2017 Feb; 72(2):150-158. PubMed ID: 27890421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of computed tomography imaging features and pathological features of 41 patients with pancreatic neuroendocrine tumors.
    Utsumi M; Umeda Y; Takagi K; Takashi K; Nobuoka D; Yoshida R; Shinoura S; Sadamori H; Yagi T; Fujiwara T
    Hepatogastroenterology; 2015; 62(138):441-6. PubMed ID: 25916078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
    Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
    Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-Enhanced Ultrasonography Findings Correlate with Pathologic Grades of Pancreatic Neuroendocrine Tumors.
    Huang J; Chen J; Xu M; Zheng Y; Lin M; Huang G; Xie X; Xie X
    Ultrasound Med Biol; 2021 Aug; 47(8):2097-2106. PubMed ID: 33934943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
    Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
    Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.
    Canellas R; Burk KS; Parakh A; Sahani DV
    AJR Am J Roentgenol; 2018 Feb; 210(2):341-346. PubMed ID: 29140113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.